Unique features of breast cancer in Asian women—Breast cancer in Taiwan as an example

[1]  Yun-Mi Song,et al.  Obesity and risk of cancer in postmenopausal Korean women. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Ulrich,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[3]  Ian O Ellis,et al.  Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[5]  Wolfgang Heller,et al.  Triple-negative breast cancer: therapeutic options. , 2007, The Lancet. Oncology.

[6]  W. Pan,et al.  A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. , 2006, Journal of biomedical science.

[7]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[8]  Chiun Hsu,et al.  Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[9]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[10]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility , 2005, International journal of cancer.

[11]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[12]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[14]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[15]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[16]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[17]  Chiun-Sheng Huang,et al.  Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) , 1998, International journal of cancer.

[18]  K. Yoo,et al.  Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. , 1997, American journal of epidemiology.

[19]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[20]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[21]  M. Pike,et al.  Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies , 1990, Cancer Causes & Control.

[22]  C. W. Wu,et al.  A case-control study of breast cancer in Taiwan--a low-incidence area. , 1997, British Journal of Cancer.